Evaluation of 1H magnetic resonance spectroscopic imaging as a diagnostic tool for the lateralization of epileptogenic seizure foci

British Journal of Radiology

Volumn 69, Issue 817, 1996, Pages 15-24

  Constantinidis, I ^a   Malko, J A ^a   Peterman, S B ^a   Long Jr , R C ^a   Epstein, C M ^a   Boor, D ^a   Hoffman Jr , J C ^a   Shutter, L ^a   Weissman, J D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID; DIAGNOSTIC AGENT; PROTON;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAPHY; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; CASE CONTROL STUDY; CHRONIC DISEASE; CLINICAL PROTOCOL; COMPARATIVE STUDY; MIDDLE AGED; OBSERVER VARIATION; PATHOPHYSIOLOGY; TREATMENT FAILURE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; CLINICAL PROTOCOLS; EPILEPSY, TEMPORAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; OBSERVER VARIATION; PROTONS; TREATMENT FAILURE;

EID: 0029665469     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/0007-1285-69-817-15     Document Type: Article

References (31)

1. ROGAWSKI, M A and PORTER, R J, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev., 42, 223-286 (1990).
2. PAWLIK, G, FINK, G R, KESSLER, J and HEISS, W-D, PET and functional testing in temporal lobe epilepsy. Acta Neurol. Scand., 152 (Suppl.), 150-156 (1994).
3. JACK, C R JR, MRI-based hippocampal volume measurements in epilepsy, Epilepsia, 35 (Suppl. 6), S21-S29 (1994).
4. 31P MRS, Epilepsia, 33, 618-623 (1992).
5. 31P magnetic resonance spectroscopic imaging, Neurology, 42, 2011-2018 (1992).
6. 31P nuclear magnetic resonance spectroscopy of human temporal lobe epilepsy, Neurology, 42, 1586-1590 (1992).
7. GARCIA, P A, LAXER, K D, VAN DER GROND, J ET AL. Phosphorous magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy, Ann. Neurol., 35, 217-221 (1994).
8. MATTHEWS, P M, ANDERMANN, F and ARNOLD, D L, A proton magnetic resonance spectroscopy study of focal epilepsy in humans, Neurology, 40, 985-989 (1990).
9. HUGG, J W, LAXER, K D, MATSON, G B ET AL, Neuron loss localizes human focal epilepsy by in vivo proton MR spectroscopic imaging, Ann. Neurol., 34, 788-794 (1993).
10. CENDES, F, ANDERMANN, F, PREUL, M C and ARNOLD, D L, Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann. Neurol., 35, 211-216 (1994).
11. BREITER, S N, ARROYO, S, MATHEWS, V P ET AL, Proton MR spectroscopy in patients with seizure disorders, Am. J. Neuroradiol., 15, 373-384 (1994).
12. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy, Acta Neurol. Scand., (Suppl. 152), 116-121 (1994).
13. CONNELY, A, JACKSON, G D, DUNCAN, J S ET AL, Magnetic resonance spectroscopy in temporal lobe epilepsy, Neurology, 44, 1411-1417 (1994).
14. VAINIO, P, USENIUS, J P, VAPALAHTI, M ET AL, Reduced N-acetylaspartate concentration in temporal lobe epilepsy by quantitative 1H MRS in vivo, NeuroReport, 5, 1733-1736 (1994).
15. NG, T C, COMAIR, Y G, XUE, M ET AL, Temporal lobe epilepsy: Presurgical localization with proton chemical shift imaging, Radiology, 193, 465-472 (1994).
16. PRICHARD, J W, Nuclear magnetic resonance spectroscopy of seizure states, Epilepsia, 35 (Suppl. 6), S14-S20 (1994).
17. BROWN, T R, KINCAID, B M and UGURBIL, K, NMR chemical shift imaging in three dimensions, Proc. Natl. Acad. Sci. USA, 79, 3523-3526 (1982).
18. MAUDSLEY, A A, HILAL, S K, PERMAN, W H and SIMON, H E, Spatially resolved high resolution spectroscopy by four dimensions, J. Magn Reson., 51, 147-152 (1983)
19. BOTTOMLEY, P A, Selective volume method for performing localized NMR spectroscopy, US Patent, 4480228 (1984).
20. FLEISS, J L. Statistical Rates of Methods and Proportions (2nd edn) (J Wiley & Sons, New York), pp. 225-232 (1981)
21. 1H nuclear magnetic resonance study. Pediatric Res., 29, 191-195 (1991).
22. 31P nuclear magnetic resonance spectroscopic studies of bicuculline-induced seizures in vivo, Ann. Neurol., 20, 185-193 (1986).
23. PETROFF, O A C, SPENCER, D D, ALGER, J R and PRICHARD, J W, High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy, Neurology, 39, 1197-1202 (1989).
24. 1H magnetic resonance spectroscopy of extracts of human epileptic neocortex and hippocampus. Neurology, 43, 589-594 (1993).
25. LANDIS, J R, and KOCH, G G, The measurement of observer agreement for categorical data, Biometrics, 33, 159-174 (1977).
26. MATHIESON, G, Pathology of the temporal lobe foci. In Complex Partial Seizures and their Treatment, ed. by J K Penry and D D Daddy (Raven Press, New York), pp. 163-185 (1975).
27. BRUTON, C J, The Neuropathotogy of Temporal Lobe Epilepsy (Oxford University Press, Oxford), pp. 1-158 (1988).
28. JACKSON, G D, BERKOVIC, S F, TRESS, B M ET AL, Hippocampal sclerosis can be reliably detected by magnetic resonance imaging, Neurology, 40, 1869-1875 (1990).
29. JACKSON, G D, BERKOVIC, S F, DUNCAN, J S and CONNELLY, A, Optimizing the diagnosis of hippocampal sclerosis using MR imaging, AJNR, 14, 753-762 (1993).
30. KUZNIECKY, R, BURGARD, S, FAUGHT, E ET AL, Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery, Arch. Neurol., 50, 65-69 (1993).
31. GIROUD, J, WALKER, P, BERNARD, D ET AL, Preliminary observations of metabolic characterization of bilateral temporal epileptic focus, using proton magnetic resonance spectroscopy. Three cases, Neurol. Res., 16, 481-483 (1994).